Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

The proposed mechanisms of action of CBD in epilepsy.

Gray RA, Whalley BJ.

Epileptic Disord. 2020 Jan 1;22(S1):10-15. doi: 10.1684/epd.2020.1135.

PMID:
32053110
2.

Anabolic Androgenic Steroid Abuse in the United Kingdom; An Update The increasing popularity of anabolic androgenic steroids.

Mullen C, Whalley BJ, Schifano F, Baker JS.

Br J Pharmacol. 2020 Jan 28. doi: 10.1111/bph.14995. [Epub ahead of print] Review.

PMID:
31989581
3.

Diving and mental health: the potential benefits and risks from a survey of recreational scuba divers.

St Leger Dowse M, Whalley B, Waterman MK, Conway RM, Smerdon GR.

Diving Hyperb Med. 2019 Dec 20;49(4):291-297. doi: 10.28920/dhm49.4.291-297.

PMID:
31828748
4.
5.

A new mechanism for cannabidiol in regulating the one-carbon cycle and methionine levels in Dictyostelium and in mammalian epilepsy models.

Perry CJ, Finch P, Müller-Taubenberger A, Leung KY, Warren EC, Damstra-Oddy J, Sharma D, Patra PH, Glyn S, Boberska J, Stewart B, Baldwin A, Piscitelli F, Harvey RJ, Harwood A, Thompson C, Claus SP, Greene NDE, McNeish AJ, Williams CM, Whalley BJ, Williams RSB.

Br J Pharmacol. 2020 Feb;177(4):912-928. doi: 10.1111/bph.14892. Epub 2020 Jan 3.

6.

Refractory depression - cost-effectiveness of radically open dialectical behaviour therapy: findings of economic evaluation of RefraMED trial.

Shearer J, Lynch TR, Chamba R, Clarke S, Hempel RJ, Kingdon DG, O'Mahen H, Remington B, Rushbrook SC, Russell IT, Stanton M, Swales M, Watkins A, Whalley B, Byford S.

BJPsych Open. 2019 Sep;5(5):e64. doi: 10.1192/bjo.2019.57.

7.

Refractory depression - mechanisms and efficacy of radically open dialectical behaviour therapy (RefraMED): findings of a randomised trial on benefits and harms.

Lynch TR, Hempel RJ, Whalley B, Byford S, Chamba R, Clarke P, Clarke S, Kingdon DG, O'Mahen H, Remington B, Rushbrook SC, Shearer J, Stanton M, Swales M, Watkins A, Russell IT.

Br J Psychiatry. 2019 Jul 18:1-9. doi: 10.1192/bjp.2019.53. [Epub ahead of print]

PMID:
31317843
8.

The Cannabinoid-Like Compound, VSN16R, Acts on Large Conductance, Ca2+-Activated K+ Channels to Modulate Hippocampal CA1 Pyramidal Neuron Firing.

Tabatabaee S, Baker D, Selwood DL, Whalley BJ, Stephens GJ.

Pharmaceuticals (Basel). 2019 Jul 4;12(3). pii: E104. doi: 10.3390/ph12030104.

9.

Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol.

Brierley DI, Harman JR, Giallourou N, Leishman E, Roashan AE, Mellows BAD, Bradshaw HB, Swann JR, Patel K, Whalley BJ, Williams CM.

J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):844-859. doi: 10.1002/jcsm.12426. Epub 2019 Apr 29.

10.

Cannabidiol modulates phosphorylated rpS6 signalling in a zebrafish model of Tuberous Sclerosis Complex.

Serra I, Scheldeman C, Bazelot M, Whalley BJ, Dallas ML, de Witte PAM, Williams CM.

Behav Brain Res. 2019 May 2;363:135-144. doi: 10.1016/j.bbr.2019.01.040. Epub 2019 Jan 23.

PMID:
30684511
11.

Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models.

Patra PH, Barker-Haliski M, White HS, Whalley BJ, Glyn S, Sandhu H, Jones N, Bazelot M, Williams CM, McNeish AJ.

Epilepsia. 2019 Feb;60(2):303-314. doi: 10.1111/epi.14629. Epub 2018 Dec 26.

12.

Radically open dialectical behaviour therapy for refractory depression: the RefraMED RCT.

Lynch TR, Hempel RJ, Whalley B, Byford S, Chamba R, Clarke P, Clarke S, Kingdon D, O’Mahen H, Remington B, Rushbrook SC, Shearer J, Stanton M, Swales M, Watkins A, Russell IT.

Southampton (UK): NIHR Journals Library; 2018 Dec.

13.

Validation of the person-centred coordinated care experience questionnaire (P3CEQ).

Lloyd H, Fosh B, Whalley B, Byng R, Close J.

Int J Qual Health Care. 2019 Aug 1;31(7):506-512. doi: 10.1093/intqhc/mzy212.

14.

Functional imagery training versus motivational interviewing for weight loss: a randomised controlled trial of brief individual interventions for overweight and obesity.

Solbrig L, Whalley B, Kavanagh DJ, May J, Parkin T, Jones R, Andrade J.

Int J Obes (Lond). 2019 Apr;43(4):883-894. doi: 10.1038/s41366-018-0122-1. Epub 2018 Sep 5.

PMID:
30185920
15.

Intention insertion: Activating an action's perceptual consequences is sufficient to induce non-willed motor behavior.

Colton J, Bach P, Whalley B, Mitchell C.

J Exp Psychol Gen. 2018 Aug;147(8):1256-1263. doi: 10.1037/xge0000435. Epub 2018 Jul 5.

PMID:
29975079
16.

Learning-induced modulation of the effect of neuroglial transmission on synaptic plasticity.

Jammal L, Whalley B, Barkai E.

J Neurophysiol. 2018 Jun 1;119(6):2373-2379. doi: 10.1152/jn.00101.2018. Epub 2018 Mar 21.

17.

Species-specific susceptibility to cannabis-induced convulsions.

Whalley BJ, Lin H, Bell L, Hill T, Patel A, Gray RA, Elizabeth Roberts C, Devinsky O, Bazelot M, Williams CM, Stephens GJ.

Br J Pharmacol. 2019 May;176(10):1506-1523. doi: 10.1111/bph.14165. Epub 2018 Mar 25.

18.

Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis.

Richards SH, Anderson L, Jenkinson CE, Whalley B, Rees K, Davies P, Bennett P, Liu Z, West R, Thompson DR, Taylor RS.

Eur J Prev Cardiol. 2018 Feb;25(3):247-259. doi: 10.1177/2047487317739978. Epub 2017 Dec 7.

19.

mTOR-related neuropathology in mutant tsc2 zebrafish: Phenotypic, transcriptomic and pharmacological analysis.

Scheldeman C, Mills JD, Siekierska A, Serra I, Copmans D, Iyer AM, Whalley BJ, Maes J, Jansen AC, Lagae L, Aronica E, de Witte PAM.

Neurobiol Dis. 2017 Dec;108:225-237. doi: 10.1016/j.nbd.2017.09.004. Epub 2017 Sep 6.

PMID:
28888969
20.

Sonic hedgehog signalling mediates astrocyte crosstalk with neurons to confer neuroprotection.

Ugbode CI, Smith I, Whalley BJ, Hirst WD, Rattray M.

J Neurochem. 2017 Aug;142(3):429-443. doi: 10.1111/jnc.14064. Epub 2017 Jun 20.

21.

Psychological interventions for coronary heart disease.

Richards SH, Anderson L, Jenkinson CE, Whalley B, Rees K, Davies P, Bennett P, Liu Z, West R, Thompson DR, Taylor RS.

Cochrane Database Syst Rev. 2017 Apr 28;4:CD002902. doi: 10.1002/14651858.CD002902.pub4. Review.

22.

Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.

Rosenberg EC, Patra PH, Whalley BJ.

Epilepsy Behav. 2017 May;70(Pt B):319-327. doi: 10.1016/j.yebeh.2016.11.006. Epub 2017 Feb 9. Review.

23.

Evaluation of Possible Consequences of Zika Virus Infection in the Developing Nervous System.

Walter LT, Higa GSV, Ikebara JM, Vedovello D, Salvador FS, Takada SH, Kinjo ER, Whalley BJ, Sperança MA, Kihara AH.

Mol Neurobiol. 2018 Feb;55(2):1620-1629. doi: 10.1007/s12035-017-0442-5. Epub 2017 Feb 11. Review.

PMID:
28190239
24.

A cannabigerol-rich Cannabis sativa extract, devoid of [INCREMENT]9-tetrahydrocannabinol, elicits hyperphagia in rats.

Brierley DI, Samuels J, Duncan M, Whalley BJ, Williams CM.

Behav Pharmacol. 2017 Jun;28(4):280-284. doi: 10.1097/FBP.0000000000000285.

PMID:
28125508
25.

Molecular Pharmacology of Phytocannabinoids.

Turner SE, Williams CM, Iversen L, Whalley BJ.

Prog Chem Org Nat Prod. 2017;103:61-101. doi: 10.1007/978-3-319-45541-9_3. Review.

PMID:
28120231
26.

Astrocytic transporters in Alzheimer's disease.

Ugbode C, Hu Y, Whalley B, Peers C, Rattray M, Dallas ML.

Biochem J. 2017 Feb 1;474(3):333-355. doi: 10.1042/BCJ20160505. Review.

PMID:
28108584
27.

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, Bewick M, Bindslev-Jensen C, Bosnic-Anticevitch S, Bucca C, Caimmi DP, Camargos PA, Canonica GW, Casale T, Chavannes NH, Cruz AA, De Carlo G, Dahl R, Demoly P, Devillier P, Fonseca J, Fokkens WJ, Guldemond NA, Haahtela T, Illario M, Just J, Keil T, Klimek L, Kuna P, Larenas-Linnemann D, Morais-Almeida M, Mullol J, Murray R, Naclerio R, O'Hehir RE, Papadopoulos NG, Pawankar R, Potter P, Ryan D, Samolinski B, Schunemann HJ, Sheikh A, Simons FE, Stellato C, Todo-Bom A, Tomazic PV, Valiulis A, Valovirta E, Ventura MT, Wickman M, Young I, Yorgancioglu A, Zuberbier T, Aberer W, Akdis CA, Akdis M, Annesi-Maesano I, Ankri J, Ansotegui IJ, Anto JM, Arnavielhe S, Asarnoj A, Arshad H, Avolio F, Baiardini I, Barbara C, Barbagallo M, Bateman ED, Beghé B, Bel EH, Bennoor KS, Benson M, Białoszewski AZ, Bieber T, Bjermer L, Blain H, Blasi F, Boner AL, Bonini M, Bonini S, Bosse I, Bouchard J, Boulet LP, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Bunu C, Burte E, Bush A, Caballero-Fonseca F, Calderon MA, Camuzat T, Cardona V, Carreiro-Martins P, Carriazo AM, Carlsen KH, Carr W, Cepeda Sarabia AM, Cesari M, Chatzi L, Chiron R, Chivato T, Chkhartishvili E, Chuchalin AG, Chung KF, Ciprandi G, de Sousa JC, Cox L, Crooks G, Custovic A, Dahlen SE, Darsow U, Dedeu T, Deleanu D, Denburg JA, De Vries G, Didier A, Dinh-Xuan AT, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Du Toit G, Dykewicz MS, Eklund P, El-Gamal Y, Ellers E, Emuzyte R, Farrell J, Fink Wagner A, Fiocchi A, Fletcher M, Forastiere F, Gaga M, Gamkrelidze A, Gemicioğlu B, Gereda JE, van Wick RG, González Diaz S, Grisle I, Grouse L, Gutter Z, Guzmán MA, Hellquist-Dahl B, Heinrich J, Horak F, Hourihane JO, Humbert M, Hyland M, Iaccarino G, Jares EJ, Jeandel C, Johnston SL, Joos G, Jonquet O, Jung KS, Jutel M, Kaidashev I, Khaitov M, Kalayci O, Kalyoncu AF, Kardas P, Keith PK, Kerkhof M, Kerstjens HA, Khaltaev N, Kogevinas M, Kolek V, Koppelman GH, Kowalski ML, Kuitunen M, Kull I, Kvedariene V, Lambrecht B, Lau S, Laune D, Le LT, Lieberman P, Lipworth B, Li J, Lodrup Carlsen KC, Louis R, Lupinek C, MacNee W, Magar Y, Magnan A, Mahboub B, Maier D, Majer I, Malva J, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Mathieu-Dupas E, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Mercier J, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Millot-Keurinck J, Mohammad Y, Momas I, Mösges R, Muraro A, Namazova-Baranova L, Nadif R, Neffen H, Nekam K, Nieto A, Niggemann B, Nogueira-Silva L, Nogues M, Nyembue TD, Ohta K, Okamoto Y, Okubo K, Olive-Elias M, Ouedraogo S, Paggiaro P, Pali-Schöll I, Palkonen S, Panzner P, Papi A, Park HS, Passalacqua G, Pedersen S, Pereira AM, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov TA, Portejoie F, Postma D, Poulsen LK, Price D, Rabe KF, Raciborski F, Roberts G, Robalo-Cordeiro C, Rodenas F, Rodriguez-Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rottem M, Sanchez-Borges M, Sastre-Dominguez J, Scadding GK, Scichilone N, Schmid-Grendelmeier P, Serrano E, Shields M, Siroux V, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Sterk PJ, Strandberg T, Sunyer J, Thijs C, Triggiani M, Valenta R, Valero A, van Eerd M, van Ganse E, van Hague M, Vandenplas O, Varona LL, Vellas B, Vezzani G, Vazankari T, Viegi G, Vontetsianos T, Wagenmann M, Walker S, Wang DY, Wahn U, Werfel T, Whalley B, Williams DM, Williams S, Wilson N, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zaidi A, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M.

Clin Transl Allergy. 2016 Dec 30;6:47. doi: 10.1186/s13601-016-0137-4. eCollection 2016. Review. Erratum in: Clin Transl Allergy. 2019 Oct 10;9:53.

28.

Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA.

Bousquet J, Bewick M, Cano A, Eklund P, Fico G, Goswami N, Guldemond NA, Henderson D, Hinkema MJ, Liotta G, Mair A, Molloy W, Monaco A, Monsonis-Paya I, Nizinska A, Papadopoulos H, Pavlickova A, Pecorelli S, Prados-Torres A, Roller-Wirnsberger RE, Somekh D, Vera-Muñoz C, Visser F, Farrell J, Malva J, Andersen Ranberg K, Camuzat T, Carriazo AM, Crooks G, Gutter Z, Iaccarino G, Manuel de Keenoy E, Moda G, Rodriguez-Mañas L, Vontetsianos T, Abreu C, Alonso J, Alonso-Bouzon C, Ankri J, Arredondo MT, Avolio F, Bedbrook A, Białoszewski AZ, Blain H, Bourret R, Cabrera-Umpierrez MF, Catala A, O'Caoimh R, Cesari M, Chavannes NH, Correia-da-Sousa J, Dedeu T, Ferrando M, Ferri M, Fokkens WJ, Garcia-Lizana F, Guérin O, Hellings PW, Haahtela T, Illario M, Inzerilli MC, Lodrup Carlsen KC, Kardas P, Keil T, Maggio M, Mendez-Zorrilla A, Menditto E, Mercier J, Michel JP, Murray R, Nogues M, O'Byrne-Maguire I, Pappa D, Parent AS, Pastorino M, Robalo-Cordeiro C, Samolinski B, Siciliano P, Teixeira AM, Tsartara SI, Valiulis A, Vandenplas O, Vasankari T, Vellas B, Vollenbroek-Hutten M, Wickman M, Yorgancioglu A, Zuberbier T, Barbagallo M, Canonica GW, Klimek L, Maggi S, Aberer W, Akdis C, Adcock IM, Agache I, Albera C, Alonso-Trujillo F, Angel Guarcia M, Annesi-Maesano I, Apostolo J, Arshad SH, Attalin V, Avignon A, Bachert C, Baroni I, Bel E, Benson M, Bescos C, Blasi F, Barbara C, Bergmann KC, Bernard PL, Bonini S, Bousquet PJ, Branchini B, Brightling CE, Bruguière V, Bunu C, Bush A, Caimmi DP, Calderon MA, Canovas G, Cardona V, Carlsen KH, Cesario A, Chkhartishvili E, Chiron R, Chivato T, Chung KF, d'Angelantonio M, De Carlo G, Cholley D, Chorin F, Combe B, Compas B, Costa DJ, Costa E, Coste O, Coupet AL, Crepaldi G, Custovic A, Dahl R, Dahlen SE, Demoly P, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Du Toit G, Dubakiene R, Dupeyron A, Emuzyte R, Fiocchi A, Wagner A, Fletcher M, Fonseca J, Fougère B, Gamkrelidze A, Garces G, Garcia-Aymeric J, Garcia-Zapirain B, Gemicioğlu B, Gouder C, Hellquist-Dahl B, Hermosilla-Gimeno I, Héve D, Holland C, Humbert M, Hyland M, Johnston SL, Just J, Jutel M, Kaidashev IP, Khaitov M, Kalayci O, Kalyoncu AF, Keijser W, Kerstjens H, Knezović J, Kowalski M, Koppelman GH, Kotska T, Kovac M, Kull I, Kuna P, Kvedariene V, Lepore V, MacNee W, Maggio M, Magnan A, Majer I, Manning P, Marcucci M, Marti T, Masoli M, Melen E, Miculinic N, Mihaltan F, Milenkovic B, Millot-Keurinck J, Mlinarić H, Momas I, Montefort S, Morais-Almeida M, Moreno-Casbas T, Mösges R, Mullol J, Nadif R, Nalin M, Navarro-Pardo E, Nekam K, Ninot G, Paccard D, Pais S, Palummeri E, Panzner P, Papadopoulos NK, Papanikolaou C, Passalacqua G, Pastor E, Perrot M, Plavec D, Popov TA, Postma DS, Price D, Raffort N, Reuzeau JC, Robine JM, Rodenas F, Robusto F, Roche N, Romano A, Romano V, Rosado-Pinto J, Roubille F, Ruiz F, Ryan D, Salcedo T, Schmid-Grendelmeier P, Schulz H, Schunemann HJ, Serrano E, Sheikh A, Shields M, Siafakas N, Scichilone N, Siciliano P, Skrindo I, Smit HA, Sourdet S, Sousa-Costa E, Spranger O, Sooronbaev T, Sruk V, Sterk PJ, Todo-Bom A, Touchon J, Tramontano D, Triggiani M, Tsartara SI, Valero AL, Valovirta E, van Ganse E, van Hage M, van den Berge M, Vandenplas O, Ventura MT, Vergara I, Vezzani G, Vidal D, Viegi G, Wagemann M, Whalley B, Wickman M, Wilson N, Yiallouros PK, Žagar M, Zaidi A, Zidarn M, Hoogerwerf EJ, Usero J, Zuffada R, Senn A, de Oliveira-Alves B.

J Nutr Health Aging. 2017;21(1):92-104. doi: 10.1007/s12603-016-0803-1.

29.

Characterisation of Development and Electrophysiological Mechanisms Underlying Rhythmicity of the Avian Lymph Heart.

Jaffer S, Valasek P, Luke G, Batarfi M, Whalley BJ, Patel K.

PLoS One. 2016 Dec 8;11(12):e0166428. doi: 10.1371/journal.pone.0166428. eCollection 2016.

30.

The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats.

de Carvalho CR, Hoeller AA, Franco PL, Martini AP, Soares FM, Lin K, Prediger RD, Whalley BJ, Walz R.

Epilepsy Res. 2016 Nov;127:160-167. doi: 10.1016/j.eplepsyres.2016.08.011. Epub 2016 Aug 29.

PMID:
27608434
31.

Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat.

Abbassian H, Whalley BJ, Sheibani V, Shabani M.

Br J Pharmacol. 2016 Nov;173(22):3196-3207. doi: 10.1111/bph.13581. Epub 2016 Oct 4.

32.

Preference for different relaxation techniques by COPD patients: comparison between six techniques.

Hyland ME, Halpin DM, Blake S, Seamark C, Pinnuck M, Ward D, Whalley B, Greaves CJ, Hawkins AL, Seamark D.

Int J Chron Obstruct Pulmon Dis. 2016 Sep 19;11:2315-2319. eCollection 2016.

33.

The neurogenesis of P1 and N1: A concurrent EEG/LFP study.

Bruyns-Haylett M, Luo J, Kennerley AJ, Harris S, Boorman L, Milne E, Vautrelle N, Hayashi Y, Whalley BJ, Jones M, Berwick J, Riera J, Zheng Y.

Neuroimage. 2017 Feb 1;146:575-588. doi: 10.1016/j.neuroimage.2016.09.034. Epub 2016 Sep 16.

34.

Explaining unexplained pain to fibromyalgia patients: finding a narrative that is acceptable to patients and provides a rationale for evidence based interventions.

Hyland ME, Hinton C, Hill C, Whalley B, Jones RC, Davies AF.

Br J Pain. 2016 Aug;10(3):156-61. doi: 10.1177/2049463716642601. Epub 2016 Apr 11.

35.

Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats.

Brierley DI, Samuels J, Duncan M, Whalley BJ, Williams CM.

Psychopharmacology (Berl). 2016 Oct;233(19-20):3603-13. doi: 10.1007/s00213-016-4397-4. Epub 2016 Aug 9.

36.

Physiological expression of olfactory discrimination rule learning balances whole-population modulation and circuit stability in the piriform cortex network.

Jammal L, Whalley B, Ghosh S, Lamrecht R, Barkai E.

Physiol Rep. 2016 Jul;4(14). pii: e12830. doi: 10.14814/phy2.12830.

37.

Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor.

Abbassian H, Esmaeili P, Tahamtan M, Aghaei I, Vaziri Z, Sheibani V, Whalley BJ, Shabani M.

Physiol Behav. 2016 Oct 1;164(Pt A):314-20. doi: 10.1016/j.physbeh.2016.06.013. Epub 2016 Jun 15.

PMID:
27317835
38.

Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse: An Individual Patient Data Meta-analysis From Randomized Trials.

Kuyken W, Warren FC, Taylor RS, Whalley B, Crane C, Bondolfi G, Hayes R, Huijbers M, Ma H, Schweizer S, Segal Z, Speckens A, Teasdale JD, Van Heeringen K, Williams M, Byford S, Byng R, Dalgleish T.

JAMA Psychiatry. 2016 Jun 1;73(6):565-74. doi: 10.1001/jamapsychiatry.2016.0076.

39.

A Low Mortality, High Morbidity Reduced Intensity Status Epilepticus (RISE) Model of Epilepsy and Epileptogenesis in the Rat.

Modebadze T, Morgan NH, Pérès IA, Hadid RD, Amada N, Hill C, Williams C, Stanford IM, Morris CM, Jones RS, Whalley BJ, Woodhall GL.

PLoS One. 2016 Feb 24;11(2):e0147265. doi: 10.1371/journal.pone.0147265. eCollection 2016.

40.

Nuclear accumulation of myocyte muscle LIM protein is regulated by heme oxygenase 1 and correlates with cardiac function in the transition to failure.

Paudyal A, Dewan S, Ikie C, Whalley BJ, de Tombe PP, Boateng SY.

J Physiol. 2016 Jun 15;594(12):3287-305. doi: 10.1113/JP271809. Epub 2016 May 5.

41.

Understanding fear and anxiety in patients at the time of an exacerbation of chronic obstructive pulmonary disease: a qualitative study.

Halpin D, Hyland M, Blake S, Seamark C, Pinnuck M, Ward D, Whalley B, Greaves C, Hawkins A, Seamark D.

JRSM Open. 2015 Nov 18;6(12):2054270415614543. doi: 10.1177/2054270415614543. eCollection 2015 Dec.

42.

Neuronal-glial populations form functional networks in a biocompatible 3D scaffold.

Smith I, Haag M, Ugbode C, Tams D, Rattray M, Przyborski S, Bithell A, Whalley BJ.

Neurosci Lett. 2015 Nov 16;609:198-202. doi: 10.1016/j.neulet.2015.10.044. Epub 2015 Oct 19.

PMID:
26493605
43.

Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea.

Brierley DI, Samuels J, Duncan M, Whalley BJ, Williams CM.

Psychopharmacology (Berl). 2016 Jan;233(2):243-54. doi: 10.1007/s00213-015-4100-1. Epub 2015 Oct 6.

PMID:
26439367
44.

Erratum to: Cannabinoids in the Treatment of Neurological Disorders.

Devinsky O, Whalley BJ, Di Marzo V.

Neurotherapeutics. 2015 Oct;12(4):910. doi: 10.1007/s13311-015-0392-4. No abstract available.

45.

Cannabinoids in the Treatment of Neurological Disorders.

Devinsky O, Whalley BJ, Di Marzo V.

Neurotherapeutics. 2015 Oct;12(4):689-91. doi: 10.1007/s13311-015-0388-0. No abstract available. Erratum in: Neurotherapeutics. 2015 Oct;12(4):910.

46.

Cannabinoids and Epilepsy.

Rosenberg EC, Tsien RW, Whalley BJ, Devinsky O.

Neurotherapeutics. 2015 Oct;12(4):747-68. doi: 10.1007/s13311-015-0375-5. Review.

47.

Playing Tetris decreases drug and other cravings in real world settings.

Skorka-Brown J, Andrade J, Whalley B, May J.

Addict Behav. 2015 Dec;51:165-70. doi: 10.1016/j.addbeh.2015.07.020. Epub 2015 Jul 26.

PMID:
26275843
48.

Molecular Targets of Cannabidiol in Neurological Disorders.

Ibeas Bih C, Chen T, Nunn AV, Bazelot M, Dallas M, Whalley BJ.

Neurotherapeutics. 2015 Oct;12(4):699-730. doi: 10.1007/s13311-015-0377-3. Review.

49.

Refractory depression: mechanisms and evaluation of radically open dialectical behaviour therapy (RO-DBT) [REFRAMED]: protocol for randomised trial.

Lynch TR, Whalley B, Hempel RJ, Byford S, Clarke P, Clarke S, Kingdon D, O'Mahen H, Russell IT, Shearer J, Stanton M, Swales M, Watkins A, Remington B.

BMJ Open. 2015 Jul 17;5(7):e008857. doi: 10.1136/bmjopen-2015-008857.

50.

Human neural stem cell-derived cultures in three-dimensional substrates form spontaneously functional neuronal networks.

Smith I, Silveirinha V, Stein JL, de la Torre-Ubieta L, Farrimond JA, Williamson EM, Whalley BJ.

J Tissue Eng Regen Med. 2017 Apr;11(4):1022-1033. doi: 10.1002/term.2001. Epub 2015 Feb 25.

PMID:
25712225

Supplemental Content

Loading ...
Support Center